Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China
- PMID: 34983603
- PMCID: PMC8725493
- DOI: 10.1186/s13020-021-00561-9
Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China
Abstract
Background: Dizziness and vertigo are common clinical symptoms. Gastrodin injection has shown clinical effects on dizziness or vertigo. However, little is known about the effectiveness and costs of combining Gastrodin injection with conventional treatment on dizziness or vertigo in daily practice. This study aimed to analyze the clinical and economic effects of Gastrodin injection for patients with dizziness or vertigo in comparison to Extract of Ginkgo Biloba Leaves injection in real-world practice.
Methods: Data was collected from the Hospital Information System of 131 hospitals across China from January to December 2018. Patients whose primary discharge diagnosis was dizziness or vertigo according to ICD-10 diagnostic coding were included and divided into two samples: sample of dizziness or vertigo; sample of dizziness or vertigo, with the complication of cerebral infarction. Comparative analysis of the medical cost per hospitalization, hospitalization duration, effective rates, and cure rates between the group of Gastrodin injection and the group of Extract of Ginkgo Biloba Leaves injection was conducted. Propensity Score Matching was used to control potential confounding factors.
Results: In the sample of dizziness or vertigo, although there was no significant differences on hospitalization duration (P = 0.080), the group of Gastrodin injection was significantly better than the group of Extract of Ginkgo Biloba Leaves injection (P < 0.001) in terms of treatment effect and the per capita hospitalization cost. In the sample of dizziness or vertigo, with the complication of cerebral infarction, there was no significant difference (P = 0.371) in terms of hospitalization duration, but the group of Gastrodin injection was significantly better than the group of Extract of Ginkgo Biloba Leaves injection (P = 0.009) in terms of treatment effect, and significant difference regarding the per capita hospitalization cost (P < 0.001).
Conclusions: Gastrodin injection showed advantages for inpatients with dizziness or vertigo compared with Extract of Ginkgo Biloba Leaves injection. Future studies using prospective pragmatic controlled trials can test and explore more about the effects of Gastrodin injections on dizziness or vertigo.
Keywords: Dizziness; Electronic health record; Extract of Ginkgo Biloba Leaves injection; Gastrodin injection; Vertigo.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interes.
Similar articles
-
Effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of dizziness caused by cerebral arteriosclerosis: a multi-center, double-blind, randomized controlled trial.J Tradit Chin Med. 2022 Feb;42(1):83-89. doi: 10.19852/j.cnki.jtcm.20211214.001. J Tradit Chin Med. 2022. PMID: 35294126 Free PMC article. Clinical Trial.
-
Balance Training With Vibrotactile Neurofeedback and Ginkgo Biloba Extract in Age-Related Vertigo.Front Neurol. 2021 Nov 30;12:691917. doi: 10.3389/fneur.2021.691917. eCollection 2021. Front Neurol. 2021. PMID: 34917009 Free PMC article.
-
The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial.J Altern Complement Med. 2005 Feb;11(1):155-60. doi: 10.1089/acm.2005.11.155. J Altern Complement Med. 2005. PMID: 15750375 Clinical Trial.
-
[Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000].Ann Pharm Fr. 1999 Jul;57 Suppl 1:1S8-88. Ann Pharm Fr. 1999. PMID: 10481350 Review. French.
-
EGb 761: ginkgo biloba extract, Ginkor.Drugs R D. 2003;4(3):188-93. doi: 10.2165/00126839-200304030-00009. Drugs R D. 2003. PMID: 12757407 Review.
Cited by
-
Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease.Molecules. 2022 Sep 21;27(19):6221. doi: 10.3390/molecules27196221. Molecules. 2022. PMID: 36234757 Free PMC article. Review.
-
Efficient Biosynthesis of Gastrodin by UDP-Glycosyltransferase from Rauvolfia serpentina.J Microbiol Biotechnol. 2025 Mar 26;35:e2501002. doi: 10.4014/jmb.2501.01002. J Microbiol Biotechnol. 2025. PMID: 40147927 Free PMC article.
-
Association of Metabolic Syndrome or Weather Conditions with the Severity and Prognosis of Sudden Sensorineural Hearing Loss.J Int Adv Otol. 2024 May 23;20(3):203-209. doi: 10.5152/iao.2024.231059. J Int Adv Otol. 2024. PMID: 39158215 Free PMC article.
-
Potential Targets and Action Mechanism of Gastrodin in the Treatment of Attention-Deficit/Hyperactivity Disorder: Bioinformatics and Network Pharmacology Analysis.Evid Based Complement Alternat Med. 2022 Sep 12;2022:3607053. doi: 10.1155/2022/3607053. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36133787 Free PMC article.
-
Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury.Front Pharmacol. 2025 Feb 19;16:1539886. doi: 10.3389/fphar.2025.1539886. eCollection 2025. Front Pharmacol. 2025. PMID: 40046749 Free PMC article. Review.
References
-
- Post RE, Dickerson LM. Dizziness: a diagnostic approach. Am Fam Physician. 2010;82(4):361–368. - PubMed
-
- Qi XK, Wang XF. Master the concept, classification and diagnostic process of dizziness. Transl Med J. 2016;5(1):1–4. doi: 10.3969/j.issn.2095-3097.2016.01.001. - DOI
-
- Lu LT, Wang HW, Wang HM, Wang JD, Sang JZ. Clinical observation of salvianolate for injection in treatment of acute cerebral infarction with dizziness/vertigo as first symptom. Drug Eval Res. 2020;43(3):506–508. doi: 10.7501/j.issn.1674-6376.2020.03.026. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources